Skip to content
PubPharm
  • Flagge DeutschlandDeutsch
  • Favourites (0) (Full)
  • Contact
  • My Account
  • Log Out
  • My Account
Logo FID Pharmazie Universitätsbibliothek Braunschweig Institut für Informationssysteme
  • Advanced Search
  • Search History
  • Structure Search
  • Network Graphs
  • dtdn
  • dtdn2
  • dtdn3
  • Info Guide
  • Quiz
  • Blog
  • /vufind/Search/Results?lookfor=%22Okura%2C+Naoko%22&type=Person&sort=year/vufind/Search/Results?lookfor=%22Okura%2C+Naoko%22&type=Person&sort=yearSearch /vufind/Search2/Results?lookfor=%22Okura%2C+Naoko%22&type=Person&sort=year PubPharm (8)
1
Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients
in: Scientific reports | Vol. 10, No. 1 (2020), p. 17495
by Katayama, Y. | Yamada, T. | Chihara, Y. | +15
Loading...
2
Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment : A Review
in: Journal of clinical medicine | Vol. 9, No. 7 (2020)
by Okura, N. | Asano, M. | Uchino, J. | +6
Loading...
3
ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
in: Clinical cancer research : an official journal of the American Association for Cancer Research | Vol. 26, No. 9 (2020), p. 2244-2256
by Okura, N. | Nishioka, N. | Yamada, T. | +19
Loading...
4
Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer
in: Journal of clinical medicine | Vol. 8, No. 4 (2019)
by Nishioka, N. | Uchino, J. | Hirai, S. | +11
Loading...
5
Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
in: Cancers | Vol. 11, No. 3 (2019)
by Yoshimura, A. | Yamada, T. | Okura, N. | +10
Loading...
6
Effective combined therapy with ramucirumab for advanced pulmonary pleomorphic carcinoma
in: Respirology case reports | Vol. 6, No. 8 (2018), p. e00372
by Nishioka, N. | Kaneko, Y. | Yamada, T. | +3
Loading...
7
Successful sequential treatment of refractory tumors caused by small cell carcinoma transformation and EGFR-T790M mutation diagnosed by repeated genetic testing in a patient with lung adenocarcinoma harboring epidermal growth factor receptor mutations : A case report
in: Respiratory medicine case reports | Vol. 25 (2018), p. 261-263
by Nishioka, N. | Yamada, T. | Harita, S. | +8
Loading...
8
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations
in: BMC cancer | Vol. 18, No. 1 (2018), p. 1241
by Yoshimura, A. | Yamada, T. | Okura, N. | +11
Loading...
    • 1
    • [1]

Filter & Sort Options

Systematic Reviews Clinical Studies Patents Covid-19/SARS-CoV-2
8 Articles 8 E-Articles 8 E-Resources
2 Journal of clinical medicine 1 BMC cancer 1 Cancers 1 Clinical cancer research : an official journal ... 1 Respiratory medicine case reports 1 Respirology case reports 1 Scientific reports see all ... less ...
6 Journal Article 2 Case Reports 2 EGFR-T790M mutation 2 non-small cell lung cancer 1 *drug therapy 1 *genetics 1 *pathology 1 *therapeutic use 1 Adult 1 Aged 1 Aged, 80 and over 1 Biopsy 1 Carcinoma, Non-Small-Cell Lung 1 Docetaxel 1 Drug Resistance, Neoplasm 1 Drug resistance 1 EC 2.7.10.1 1 EGFR protein, human 1 EGFR-T790M 1 ErbB Receptors see all ... less ...
3 2020- 5 2010-2019
8 English
Haven't found what you're looking for?

Blog | About Us | Feedback

funded by 

Help | Privacy Protection | Imprint | Tutorials/Webcasts | PubPharm (V1)

beluga core 5.0.1-1.0.11
Loading...